My research activity was recognized with the prestigious ERC-Starting grant (call 2014) and the ERC Consolidator Grant (call 2020). I received >11 M€ in competitive projects. I published 70 papers in peer review journals (Cell, Cell Metabolism, Nature Materials, among others). I combine my research activity being Deputy Director [CMRB:2011-13 and IBEC:2018-today]. From January 2021 I have been selected Coordinator of the Spanish Platform for Biobanks and Biomodels from the Institute of Health Carlos III (> 40 Units accross Spain).
My fascination to understand how tissues develop have helped me to start revealing early programs that fail when organs get disease. I lead my group to develop fundamental knowledge and new bioengineered approaches to emulate the native tissue milieu. By developing new organoid model systems and human pluripotent stem cells we explore how systemic conditions (i.e., diabetes) and physical constrains (i.e., changes in extracellular matrix) can lead to disease in kidney and heart. In front of COVID19 outbreak we have adapted our research identifying therapeutic compounds to treat COVID19.